HF
PASG icon

HRT Financial’s Passage Bio PASG Stock Holding History

HRT Financial’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-693
Closed -$7K – 3168
2024
Q4 		$7K Buy
+693
New +$9.03K ﹤0.01% 2308
2023
Q2 		– Sell
-986
Closed -$18K – 3049
2023
Q1 		$18K Buy
+986
New +$26.7K ﹤0.01% 2192
2022
Q1 		– Sell
-774
Closed -$98K – 3657
2021
Q4 		$98K Sell
774
-3,252
-81% -$531K ﹤0.01% 2768
2021
Q3 		$801K Buy
+4,026
New +$960K ﹤0.01% 1502

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's PASG Position: Q1 2025 in Review

HRT Financial sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 693 shares — an estimated $7K sold.

HRT Financial first reported a position in PASG in Q3 2021 and held it in 4 quarters. The position peaked at $801K in Q3 2021. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.

  • HRT Financial reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 693 Passage Bio shares in Q1 2025, an estimated $7K.
  • HRT Financial first reported a position in Passage Bio in Q3 2021 and held it in 4 quarters.
  • HRT Financial's Passage Bio position peaked at $801K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.